The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Public Health Aspects of COVID19 Infection with Focus on Cardiovascular Diseases
Open accessAbstract
INTRODUCTION: COVID-19 is the disease caused by an infection of the SARS-CoV-2 virus, first identified in the city of Wuhan, in China's Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020. AIM: The aim of this study is to search scientific literature in the biomedicine and analyzed current results of investigations regarding morbidity and mortality rates as consequences of COVID-19 infection of Cardiovascular diseases (CVD), and other most common chronic diseases which are on the top mortality and morbidity rates in almost all countries in the world. Also, to propose most useful measures how to prevent patients to keep themselves against COVID-19 infection. METHODS: We used method of descriptive analysis of the published papers with described studies about Corona virus connected with CVD, and, also, Guidelines proposed by World Health Organization (WHO) and European Society of Cardiology (ESC), and some other international associations which are included in global fighting against COVID-19 infection. RESULTS: After searching current scientific literature we have acknowledged that not any Evidence Based Medicine (EBM) study in the world during last 5 months from the time when first cases of COVID-10 infection was detected. Also, there is no unique proposed ways of treatments and drugs to protect patients, especially people over 65 years old, who are very risk group to be affected with COVID-19. Expectations that vaccine against COVID-19 will be produced optimal during at least 10 months to 2 years, and in all current Guidelines most important proposed preventive measures are the same like which one described in Strategic documents of WHO, in statements of Declaration of Primary Health Care in Alma Ata in 1978. CONCLUSION: WHO proposed preventive measures can be helpful to everybody. Physicians who work at every level of Health Care Systems, but especially at primary health care level, must follow those recommendations and teach their patients about it. But, the fact is that current focus of COVID-19 epidemic has targeted on protection of physical health of population in global, however, the influence on mental health which will be one of the important consequences of COVID-19 pandemic in the future, and which could be declared as «Post-coronavirus Stress Syndrome" (PCSS) could be bigger challenge for Global Public Health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Comorbidity appears to be a determining factor in COVID-19 severity and prognosis.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · DergiPark (Istanbul University) · Cited by 169,621
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
Dawood, F. S., Iuliano, A., Reed, C., Meltzer, M., Shay, D., Cheng, P.-Y., Bandaranayake, D., Breiman, R., Brooks, W. A., Buchy, P., et al. (2012) · Lancet. Infectious Diseases (Print) · doi:10.1016/s1473-3099(12)70121-4 · Cited by 1,294
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yü, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,292
Coronaviruses and the cardiovascular system: acute and long-term implications
Xiong, T., Redwood, S. R., Prendergast, B., & Chen, M. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa231 · Cited by 868
Badawi, A. F., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703
Libby, P., & Simon, D. I. (2001) · Circulation · doi:10.1161/01.cir.103.13.1718 · Cited by 605
Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
Corrales‐Medina, V., Alvarez, K. N., Weissfeld, L. A., Angus, D. C., Chirinos, J. A., Chang, C.-C. H., Newman, A. B., Loehr, L. R., Folsom, A. R., Elkind, M. S. V., et al. (2015) · JAMA · doi:10.1001/jama.2014.18229 · Cited by 602
Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
Wu, Q., Zhou, L., Sun, X., Yan, Z., Hu, C., Wu, J., Xu, L., Li, X., Liu, H., Yin, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09536-z · Cited by 439
Seasonal Influenza Infections and Cardiovascular Disease Mortality
Nguyen, J. L., Yang, W., Ito, K., Matte, T., Shaman, J. L., & Kinney, P. L. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0433 · Cited by 397
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Patel, A. B., & Verma, A. (2020) · JAMA · doi:10.1001/jama.2020.4812 · Cited by 378
Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
Bailly, C. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152956 · Cited by 208
Left Ventricular Performance in Patients With Severe Acute Respiratory Syndrome
Li, S. S.-L., Cheng, C.-W., Fu, C.-L., Chan, Y.-H., Lee, M.-P., Chan, J. W.-M., & Yiu, S. F. (2003) · Circulation · doi:10.1161/01.cir.0000094737.21775.32 · Cited by 207
The 2019 Novel Coronavirus Outbreak - A Global Threat.
Khot, W. Y., & Nadkar, M. (2020) · PubMed · Cited by 102
The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
Hassan, S., Jawad, M. J., Ahjel, S. W., Singh, R. P., Singh, J., Awad, S. M., & Hadi, N. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.134-138 · Cited by 55
Harris, J. E., Shah, P. J., Korimilli, V., & Win, H. K. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2018.12.013 · Cited by 41
Wang, J., Xu, H., Yang, X., Zhao, D., Liu, S., Sun, X., Huang, J., & Guo, Q. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.10.005 · Cited by 33
Acute Respiratory Distress Syndrome (ARDS) from Endemic Influenza A/H1N1: Prehospital Management
Salihefendić, N., Zildžić, M., & Ahmetagić, S. (2015) · Medical Archives · doi:10.5455/medarh.2015.69.62-63 · Cited by 20
Pharmacologist's view of the new corona virus
Rajko, I. (2020) · Scripta Medica · doi:10.5937/scriptamed51-25852 · Cited by 8
Where are we now with COVID‐19?
Thomson, G. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13497 · Cited by 7
Pharmacology of the Renin-Angiotensin system
Zerem, E. (2015) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1512775z · Cited by 2
Pharmacology of the renin-angiotensin system.
Shokei, K. I. M., & 研二郎, 山. (1994) · Folia Pharmacologica Japonica · doi:10.1254/fpj.104.275 · Cited by 1
The Most Influential Scientists in the Development of Public Health (4): Andrija Stampar (1888-1958)
Mašić, I. (2019) · Materia Socio Medica · doi:10.5455/msm.2019.31.298-299 · Cited by 1
Cited by
Sorted by citations
The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19
An, X., Zhang, Y., Duan, L., Jin, D., Zhao, S., Zhou, R., Duan, Y., Lian, F., & Tong, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111267 · Cited by 101
The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
Hassan, S., Jawad, M. J., Ahjel, S. W., Singh, R. P., Singh, J., Awad, S. M., & Hadi, N. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.134-138 · Cited by 55
Kaftan, A. N., Hussain, M. K., Algenabi, A. H. A., Naser, F. H., & Enaya, M. A. (2021) · Acta Informatica Medica · doi:10.5455/aim.2021.29.45-50 · Cited by 47
Naser, N., Durak-Nalbantić, A., Nalbantic, N., & Karić, A. (2023) · Medical Archives · doi:10.5455/medarh.2023.77.105-111 · Cited by 37
Self-citationRole of NRF2 and Sirtuin activators in COVID-19
Khan, H., Patel, S., & Majumdar, A. S. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108879 · Cited by 34
Metadata
- Authors
- Naser, N., Masic, I., & Zildzic, M.
- Venue
- Materia Socio Medica
- Publisher
- ScopeMed
- Published
- 2020
- Volume
- 32
- Issue
- 1
- Pages
- 71
- ISSN
- 1512-7680 (ISSN-L)
- PMC
- PMC7219724
- OpenAlex
- W3015746835
- Cited by
- 38
- References
- 26
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 15 · 2020: 9
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Materia Socio Medica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Keywords
- COVID-19 pandemic, SARS-CoV-2, cardiovascular disease, COVID-19 mortality, COVID-19 morbidity, chronic disease, COVID-19 prevention, WHO guidelines, ESC guidelines, primary care, elderly patients, COVID-19 vaccines, mental health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
